23 research outputs found

    Characterizing the Experience of Tapentadol Nonmedical Use: Mixed Methods Study

    No full text
    BackgroundThe prevalence of abuse, diversion, and web-based endorsement of tapentadol (extended-release [ER], immediate-release [IR]) has been characterized as low compared with other prescription opioids. Little is known about individual experience with tapentadol nonmedical use (NMU). ObjectiveThis study aims to pilot web-based survey technologies to investigate the motivation for tapentadol NMU, sources of procurement, routes of administration, tampering methods, doses used, and impressions of tapentadol products (Nucynta and Nucynta ER). MethodsRecruitment flyers and banner advertisements were placed on the Bluelight website [DragonByte Technologies Ltd] with a link to a web-based survey (Qualtrics) designed to query about individuals’ lifetime tapentadol NMU. This web-based survey was followed by an interactive web-based chat (Cryptocat) with respondents who were willing to be contacted. Respondents were queried about sources for obtaining tapentadol, motives for use, routes of administration, tampering methods, drugs used in combination, tablet strengths and dosages, and reasons for continued or discontinued use. Desirability and attractiveness for NMU was rated. ResultsWeb-based recruitment successfully attracted difficult-to-find study participants. A total of 78 participants reported that tapentadol was obtained from friends and family (ER 11/30, 37%; IR 18/67, 27%), the internet (ER 11/30, 37%; IR 12/67, 18%) or participants’ own prescriptions from a doctor (ER 9/30, 30%; IR 17/67, 25%). It was used nonmedically for pain relief (ER 18/30, 60%; IR 33/67, 49%) and multiple psychotropic effects, including relaxation (ER 13/30, 43%; IR 29/67, 43%), reduction in depression or anxiety (ER 7/30, 23%; IR 30/67, 45%), or getting high (ER 12/30, 40%; IR 33/67, 49%). Tapentadol was primarily swallowed (ER 22/30, 73%; IR 55/67, 82%), although snorting (ER 2/30, 7%; IR 8/67, 12%) and injection (ER 2/30, 7%; IR 5/67, 8%) were also reported. The preferred dose for NMU was 100 mg (both ER and IR). The participants reported tapentadol use with benzodiazepines (ER 12/21, 57%; IR 28/47, 60%). Most participants had discontinued tapentadol NMU at the time of survey completion (ER 22/30, 73%; IR 55/67, 82%). Reasons for discontinued ER NMU included side effects (10/22, 46%) and lack of effective treatment (10/22, 46%). Reasons for discontinued IR NMU included lack of access (26/55, 47%) and better NMU options (IR 21/55, 38%). Few individuals were willing to divulge identifying information about themselves for the interactive chat (8/78, 10%), demonstrating the strength of anonymous, web-based surveys. Interactive chat supported the survey findings. A subgroup of participants (4/78, 5%) reported hallucinogenic side effects with high doses. ConclusionsWeb-based surveys can successfully recruit individuals who report drug NMU and those who are difficult to find. Tapentadol NMU appears to occur primarily for pain relief and for its psychotropic effects. Although it was liked by some, tapentadol did not receive a robust pattern of endorsement for NMU

    Off-plane grating spectrometer for the International X-ray Observatory

    No full text
    A dispersive spectrometer onboard the International X-ray Observatory (IXO) provides a method for high throughput and high spectral resolution at X-ray energies below 1 keV. An off-plane reflection grating array maximizes these capabilities. We present here a mature mechanical design that places the grating array on the spacecraft avionics bus 13.5 m away from the focal plane. In addition, we present the technology development plan for advancing the Technology Readiness Level to 6 for the Off-Plane X-ray Grating Spectrometer

    sj-csv-1-hpq-10.1177_13591053221123842 – Supplemental material for Romantic partner undermining of weight loss: Links between overweight individuals’ weight management efforts and perceptions of their partner’s undermining motivations and behaviors

    No full text
    Supplemental material, sj-csv-1-hpq-10.1177_13591053221123842 for Romantic partner undermining of weight loss: Links between overweight individuals’ weight management efforts and perceptions of their partner’s undermining motivations and behaviors by René M Dailey, Rachel Lloyd, Suzanne Burdick, Zhengyu Zhang and Rebecca Kurlak in Journal of Health Psychology</p

    sj-docx-5-hpq-10.1177_13591053221123842 – Supplemental material for Romantic partner undermining of weight loss: Links between overweight individuals’ weight management efforts and perceptions of their partner’s undermining motivations and behaviors

    No full text
    Supplemental material, sj-docx-5-hpq-10.1177_13591053221123842 for Romantic partner undermining of weight loss: Links between overweight individuals’ weight management efforts and perceptions of their partner’s undermining motivations and behaviors by René M Dailey, Rachel Lloyd, Suzanne Burdick, Zhengyu Zhang and Rebecca Kurlak in Journal of Health Psychology</p

    sj-docx-4-hpq-10.1177_13591053221123842 – Supplemental material for Romantic partner undermining of weight loss: Links between overweight individuals’ weight management efforts and perceptions of their partner’s undermining motivations and behaviors

    No full text
    Supplemental material, sj-docx-4-hpq-10.1177_13591053221123842 for Romantic partner undermining of weight loss: Links between overweight individuals’ weight management efforts and perceptions of their partner’s undermining motivations and behaviors by René M Dailey, Rachel Lloyd, Suzanne Burdick, Zhengyu Zhang and Rebecca Kurlak in Journal of Health Psychology</p

    sj-docx-3-hpq-10.1177_13591053221123842 – Supplemental material for Romantic partner undermining of weight loss: Links between overweight individuals’ weight management efforts and perceptions of their partner’s undermining motivations and behaviors

    No full text
    Supplemental material, sj-docx-3-hpq-10.1177_13591053221123842 for Romantic partner undermining of weight loss: Links between overweight individuals’ weight management efforts and perceptions of their partner’s undermining motivations and behaviors by René M Dailey, Rachel Lloyd, Suzanne Burdick, Zhengyu Zhang and Rebecca Kurlak in Journal of Health Psychology</p

    sj-docx-2-hpq-10.1177_13591053221123842 – Supplemental material for Romantic partner undermining of weight loss: Links between overweight individuals’ weight management efforts and perceptions of their partner’s undermining motivations and behaviors

    No full text
    Supplemental material, sj-docx-2-hpq-10.1177_13591053221123842 for Romantic partner undermining of weight loss: Links between overweight individuals’ weight management efforts and perceptions of their partner’s undermining motivations and behaviors by René M Dailey, Rachel Lloyd, Suzanne Burdick, Zhengyu Zhang and Rebecca Kurlak in Journal of Health Psychology</p

    Adolescent ethanol drinking promotes hyperalgesia, neuroinflammation and serotonergic deficits in mice that persist into adulthood

    No full text
    Khan, K. M., Bierlein-De La Rosa, G., Biggerstaff, N., Selvakumar, G. P., Wang, R., Mason, S., Dailey, M. E., & Marcinkiewcz, C. A. (2023). “Adolescent Ethanol Drinking Promotes Hyperalgesia, Neuroinflammation and Serotonergic Deficits in Mice that Persist into Adulthood.” Brain Behavior and Immunity, 107, 419–431. doi.org/10.1016/j.bbi.2022.07.16
    corecore